Burkett Financial Services’s Alnylam Pharmaceuticals ALNY Stock Holding History

Burkett Financial Services’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$36.8K	Buy	+149	New	+$37.9K	0.01%	185

Other funds holding ALNY

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Laurie J. Hall Trustee $314M AUM 27.43% 1-Year Est. Return

Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return

Burkett Financial Services's ALNY Position: Q3 2026 in Review

Burkett Financial Services opened a new position in Alnylam Pharmaceuticals (ALNY) in Q3 2026: 149 shares worth $36.8K. The stake represents 0.01% of the portfolio and ranks #185 among its holdings.

19 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.

Burkett Financial Services held 149 shares of Alnylam Pharmaceuticals worth $36.8K as of Q3 2026.
Alnylam Pharmaceuticals was a new Burkett Financial Services position in Q3 2026.
Alnylam Pharmaceuticals made up 0.01% of Burkett Financial Services's portfolio in Q3 2026, its #185 holding.
19 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.

Based on Burkett Financial Services's 13F filing for Q3 2026, filed 1 Oct 2026.